This content is in French.
Peanut under control?
8 mai 2025
#Immunotherapy #FoodAllergy #Peanut
#Desensitization
Peanut allergy is one of the most severe and persistent food allergies. It affects up to 3% of the pediatric population in Western countries. It is a major cause of anaphylaxis and has a significant impact on the quality of life of patients and their families. The constant fear of accidental exposure causes daily stress, disrupts social life, and imposes drastic dietary restrictions. To date, management mainly relies on strict avoidance of the allergen and the use of emergency treatments in case of a reaction—an approach more focused on risk management than on a curative strategy.
Peanut allergy is one of the most severe and persistent food allergies. It affects up to 3% of the pediatric population in Western countries. It is a major cause of anaphylaxis and has a significant impact on the quality of life of patients and their families. The constant fear of accidental exposure causes daily stress, disrupts social life, and imposes drastic dietary restrictions. To date, management mainly relies on strict avoidance of the allergen and the use of emergency treatments in case of a reaction—an approach more focused on risk management than on a curative strategy.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Berkes, S., et al. Re-evaluating treatment success in trials of peanut oral-immunotherapy: impact of different definitions on efficacy outcomes. Current Opinion in Allergy and Clinical Immunology, 10-1097
View the source
